Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
US5952322A · kind A · utility
26Cited by
7References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 1997 |
| Grant date | Sep 14, 1999 |
| Priority date | — |
| Expiry date | Nov 25, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preventing non-cardiac tissue damage resulting from ischemia and/or hypoxia, comprising administering to a patient in need of such treatment an effective amount of an glycogen phosphorylase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.